TCR-Mimic Foundry: De Novo scFv Design Against Peptide-MHC Complexes

A design service that produces antibody fragments binding a chosen peptide-MHC complex on the cell surface, turning intracellular tumor or viral antigens into antibody targets — demonstrated de novo on a PHOX2B peptide-MHC complex.